Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into ...

Tesla ($TSLA) investors (and shareholders) may want to brush up on their “legalese” because the next few months could have ...

Amid wider economic uncertainty, some analysts have said that businesses are at a “no-hire, no fire” standstill.

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid ...

Over the past 25 years, Greenlanders have experienced a dramatic increase in cardiometabolic diseases, including type 2 ...

Novo Nordisk is quietly coming out of the storm despite the prevailing pessimism, especially among retail investors. Click ...

Following a challenge brought by Novo Nordisk Inc., BBB National Programs’ National Advertising Division reviewed express and implied advertising claims made by Regen Doctors, Inc. for its compounded ...

At a White House event on Nov.6 announcing price cuts for those blockbuster weight-loss drugs, Medicare and Medicaid Administrator Mehmet Oz made an ...

Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...

HealthDay News — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...